Investment
Features
FeesSafety
Academy
More
Pluang+

Compare LifeStance Health Group Inc. Common Stock (LFST) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

LifeStance Health Group Inc. Common StockTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

LifeStance Health Group Inc. Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? LifeStance Health Group Inc. Common Stock trades at $12.7 (market cap $4.76B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: LifeStance Health Group Inc. Common Stock is far larger — about 3.3× uniQure N.V. Ordinary Shares's market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold LifeStance Health Group Inc. Common Stock for 6 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

LFSTQURE
Market Cap
$4.76B$1.45B
Volume
3,444,5493,323,243
Sector
HealthHealth
52-Week High
$13.38$70.59
52-Week Low
$4.81$9.03
Typical Hold Time
6 Days0 Days
Enterprise Value
$4.99B$707.46M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

LifeStance Health Group Inc. Common Stock

LifeStance Health Group (LFST) trades at $12.32, down 1.28% today, with strong technical momentum showing a bullish moving average signal. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $0.06 exceeding the $0.03 forecast. Revenue growth accelerated from $1.42B in 2025 to $1.6B in 2026, while net income improved significantly from $9.66M to $51M.

Wall Street maintains strong bullish sentiment with 82% buy ratings and a $14.14 consensus price target representing 15% upside. However, elevated valuation multiples (P/E 94.8) and overbought technical conditions near 52-week highs warrant caution. The mental healthcare provider benefits from industry tailwinds but faces execution risks amid competitive pressures.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LFST

No sentiment data available yet.

QURE
100% Buy0% Sell
Avg holding period · 0 Days

About LifeStance Health Group Inc. Common Stock

LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.

Read more on LFST →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →